MedCanHub: a platform developed by Cellen aimed at reducing barriers of access to unlicensed cannabis-based medicinal products during the COVID-19 pandemic

Clin Med (Lond). 2021 Mar;21(Suppl 2):29-30. doi: 10.7861/clinmed.21-2-s29.

Authors

Lim Zhen Zong¹, Mala Mawkin¹, Haggai Sharon², Michael Barnes³, Panagiotis Pardalidis¹, Sarah Marten⁴, Giancarlo Camilleri⁵, Benjamin Viaris de Lesegno⁴

Affiliations

¹ Imperial College London, London, UK.
² Guy's and St Thomas' Pain Management and Neuromodulation Centre, London, UK.
³ Medical Cannabis Clinician Society.
⁴ Cellen Life Sciences.
⁵ Ashford and St Peter's NHS Foundation Trust, Surrey, UK.

PMID: 34078686
DOI: 10.7861/clinmed.21-2-s29

No abstract available

MeSH terms

COVID-19*
Cannabis*
Humans
Pandemics
SARS-CoV-2
Surveys and Questionnaires